New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is the most common chronic inflammatory autoimmune disease involving joints. Among several pathogenic mechanisms, the impairment of homeostatic regulators of inflammation seems to be critically important to sustain persistent infiltration and activation of immune and stroma...

Full description

Bibliographic Details
Main Authors: Sara Pagani, Mattia Bellan, Daniele Mauro, Luigi Mario Castello, Gian Carlo Avanzi, Myles J. Lewis, Pier Paolo Sainaghi, Costantino Pitzalis, Alessandra Nerviani
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2020/1614627
id doaj-10ff61ec1a584af5aa35e0ec66b84c67
record_format Article
spelling doaj-10ff61ec1a584af5aa35e0ec66b84c672020-11-25T00:11:19ZengHindawi LimitedDisease Markers0278-02401875-86302020-01-01202010.1155/2020/16146271614627New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid ArthritisSara Pagani0Mattia Bellan1Daniele Mauro2Luigi Mario Castello3Gian Carlo Avanzi4Myles J. Lewis5Pier Paolo Sainaghi6Costantino Pitzalis7Alessandra Nerviani8Centre for Experimental Medicine & Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UKDepartment of Translational Medicine, Università del Piemonte Orientale (UPO), Novara, ItalyCentre for Experimental Medicine & Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UKDepartment of Translational Medicine, Università del Piemonte Orientale (UPO), Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale (UPO), Novara, ItalyCentre for Experimental Medicine & Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UKDepartment of Translational Medicine, Università del Piemonte Orientale (UPO), Novara, ItalyCentre for Experimental Medicine & Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UKCentre for Experimental Medicine & Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UKRheumatoid Arthritis (RA) is the most common chronic inflammatory autoimmune disease involving joints. Among several pathogenic mechanisms, the impairment of homeostatic regulators of inflammation seems to be critically important to sustain persistent infiltration and activation of immune and stromal cells within the diseased synovium. Tyrosine kinase receptors Tyro3, Axl, and Mer are members of the TAM family. Upon binding their ligands Growth Arrest-Specific gene 6 (Gas6) and Protein S (ProS1), TAM receptors (TAMs) exert numerous and diverse biologic functions. Activated Axl and Mer, for instance, can negatively regulate the inflammatory cascade and mediate phagocytosis of apoptotic cells, contributing to prevent the development of autoimmunity. Thus, a role for TAMs has been hypothesized in RA. In this review, we will summarise unmet clinical needs in RA, depict the biology of TAMs and TAM ligands, focussing on their ability to regulate the immune system and inflammation cascade, and finally offer an overview of the state-of-the-art literature about the putative role of TAM axis in RA.http://dx.doi.org/10.1155/2020/1614627
collection DOAJ
language English
format Article
sources DOAJ
author Sara Pagani
Mattia Bellan
Daniele Mauro
Luigi Mario Castello
Gian Carlo Avanzi
Myles J. Lewis
Pier Paolo Sainaghi
Costantino Pitzalis
Alessandra Nerviani
spellingShingle Sara Pagani
Mattia Bellan
Daniele Mauro
Luigi Mario Castello
Gian Carlo Avanzi
Myles J. Lewis
Pier Paolo Sainaghi
Costantino Pitzalis
Alessandra Nerviani
New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
Disease Markers
author_facet Sara Pagani
Mattia Bellan
Daniele Mauro
Luigi Mario Castello
Gian Carlo Avanzi
Myles J. Lewis
Pier Paolo Sainaghi
Costantino Pitzalis
Alessandra Nerviani
author_sort Sara Pagani
title New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
title_short New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
title_full New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
title_fullStr New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
title_full_unstemmed New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
title_sort new insights into the role of tyro3, axl, and mer receptors in rheumatoid arthritis
publisher Hindawi Limited
series Disease Markers
issn 0278-0240
1875-8630
publishDate 2020-01-01
description Rheumatoid Arthritis (RA) is the most common chronic inflammatory autoimmune disease involving joints. Among several pathogenic mechanisms, the impairment of homeostatic regulators of inflammation seems to be critically important to sustain persistent infiltration and activation of immune and stromal cells within the diseased synovium. Tyrosine kinase receptors Tyro3, Axl, and Mer are members of the TAM family. Upon binding their ligands Growth Arrest-Specific gene 6 (Gas6) and Protein S (ProS1), TAM receptors (TAMs) exert numerous and diverse biologic functions. Activated Axl and Mer, for instance, can negatively regulate the inflammatory cascade and mediate phagocytosis of apoptotic cells, contributing to prevent the development of autoimmunity. Thus, a role for TAMs has been hypothesized in RA. In this review, we will summarise unmet clinical needs in RA, depict the biology of TAMs and TAM ligands, focussing on their ability to regulate the immune system and inflammation cascade, and finally offer an overview of the state-of-the-art literature about the putative role of TAM axis in RA.
url http://dx.doi.org/10.1155/2020/1614627
work_keys_str_mv AT sarapagani newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
AT mattiabellan newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
AT danielemauro newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
AT luigimariocastello newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
AT giancarloavanzi newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
AT mylesjlewis newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
AT pierpaolosainaghi newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
AT costantinopitzalis newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
AT alessandranerviani newinsightsintotheroleoftyro3axlandmerreceptorsinrheumatoidarthritis
_version_ 1716211969797652480